D. Perner

521 citations

22 papers · 390 indexed · h-index 9

Impact in

Hepatology top 2%
- Hepatitis C virus research
Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Hepatology 20
- Hepatitis C virus research 20
Infectious Diseases 7
- HIV/AIDS drug development and treatment 7

Co-authors: Christoph Sarrazin (17 shared papers)S. Süsser (20 shared papers)Stefan Zeuzem (16 shared papers)Johannes Vermehren (10 shared papers)Julia Dietz (6 shared papers)Stefan Zeuzem (3 shared papers)Martin Welker (2 shared papers)Nicole Forestier (1 shared paper)
Journals: Journal of Hepatology (10 papers)PLoS ONE (3 papers)Journal of Clinical Virology (3 papers)Journal of Viral Hepatitis (2 papers)Human Immunology (1 paper)
Partner nations: Germany United States Switzerland

In The Last Decade

D. Perner

22 papers receiving 389 citations

Peers

Countries citing papers authored by D. Perner

Since Specialization

Citations

This map shows the geographic impact of D. Perner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Perner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Perner more than expected).

Fields of papers citing papers by D. Perner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Perner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Perner. The network helps show where D. Perner may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Perner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Perner Line = papers co-authored together D. Perner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir Journal of Clinical Virology ·S. Süsser, Johannes Vermehren, Nicole Forestier, Martin Welker, Natalia Grigorian, C. Füller, D. Perner, Stefan Zeuzem, Christoph Sarrazin	2011	87
2	Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients PLoS ONE ·Julia Dietz, S. Süsser, C. Berkowski, D. Perner, Stefan Zeuzem, Christoph Sarrazin	2015	61
3	Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens Journal of Hepatology ·Benjamin Maasoumy, Johannes Vermehren, Martin‐Walter Welker, Birgit Bremer, D. Perner, Christoph Höner zu Siederdissen, Katja Deterding, Patrick Lehmann, Gavin Cloherty, Birgit Reinhardt, Jean–Michel Pawlotsky, Michael P. Manns, Stefan Zeuzem, Markus Cornberg, Heiner Wedemeyer, Christoph Sarrazin	2016	53
4	Interferon lambda 4 genotypes and resistance‐associated variants in patients infected with hepatitis C virus genotypes 1 and 3 Hepatology ·Kai‐Henrik Peiffer, Lisa Sommer, S. Süsser, Johannes Vermehren, Eva Herrmann, Matthias Döring, Julia Dietz, D. Perner, C. Berkowski, Stefan Zeuzem, Christoph Sarrazin	2015	36
5	Serum microRNA‐122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy Journal of Viral Hepatitis ·Verena Köberle, Oliver Waidmann, Bernd Kronenberger, A Andrei, S. Süsser, C. Füller, D. Perner, Stefan Zeuzem, Christoph Sarrazin, Albrecht Piiper	2013	33
6	Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection Journal of Clinical Virology ·Johannes Vermehren, S. Süsser, Annemarie Berger, D. Perner, Kai‐Henrik Peiffer, Regina Allwinn, Stefan Zeuzem, Christoph Sarrazin	2012	32
7	HCV RNA Quantification with Different Assays: Implications for Protease-Inhibitor-Based Response-Guided Therapy Antiviral Therapy ·Bart Fevery, S. Süsser, Oliver Lenz, Gavin Cloherty, D. Perner, Gastón Picchio, Christoph Sarrazin	2013	27
8	Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C PLoS ONE ·S. Süsser, Eva Herrmann, Christian M. Lange, Nabila Hamdi, Tobias Müller, Thomas Berg, D. Perner, Stefan Zeuzem, Christoph Sarrazin	2014	18
9	Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir Journal of Clinical Virology ·Bart Fevery, S. Süsser, Oliver Lenz, Gavin Cloherty, D. Perner, Leen Gilles, Patrick De Locht, Gastón Picchio, Sandra De Meyer, Christoph Sarrazin	2015	8
10	P0900 : Consideration of viral resistance for optimization of direct antiviral therapy of chronic hepatitis C Journal of Hepatology ·Julia Dietz, C. Berkowski, D. Perner, S. Süsser, Stefan Zeuzem, Christoph Sarrazin	2015	5
11	Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site‐directed mutagenesis of an NS4B aminoterminal basic leucine zipper Journal of Viral Hepatitis ·Martin Welker, S. Süsser, Christoph Welsch, D. Perner, C. Füller, Bernd Kronenberger, Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin	2012	4
12	IL28B gene variants and glucose metabolism in Type 2 Diabetes Human Immunology ·Y. Morán-Auth, Marissa Penna-Martinez, D. Perner, S. Süsser, Sabine Wicker, Stefan Zeuzem, Christoph Sarrazin, Klaus Badenhoop	2016	4
13	59 COMPARISON OF TWO QUANTITATIVE HCV RNA ASSAYS IN SAMPLES FROM PATIENTS TREATED WITH A PROTEASE INHIBITOR-BASED THERAPY: IMPLICATIONS FOR RESPONSE GUIDED THERAPY Journal of Hepatology ·Bart Fevery, S. Süsser, Oliver Lenz, Gavin Cloherty, D. Perner, Gastón Picchio, C. Sarrazin	2012	4
14	Ultratiefe Pyrosequenz-Analyse (UDPS) von neu beschriebenen seltenen Resistenzvarianten der Hepatitis C Virus NS3 Protease bei Patienten, die mit Telaprevir oder Boceprevir behandelt wurden Zeitschrift für Gastroenterologie ·S. Süsser, SE Schelhorn, CM Lange, Christoph Welsch, Johannes Vermehren, D. Perner, C. Füller, Thomas Lengauer, Stefan Zeuzem, Christoph Sarrazin	2012	4
15	Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy PLoS ONE ·Julia Dietz, Daniel Rupp, S. Süsser, Johannes Vermehren, Kai‐Henrik Peiffer, Natalie Filmann, Dimitra Bon, Thomas Kuntzen, Stefan Mauss, Georgios Grammatikos, D. Perner, C. Berkowski, Eva Herrmann, Stefan Zeuzem, Ralf Bartenschlager, Christoph Sarrazin	2016	3
16	P0896 : Long-term follow-up analysis of RAVs in HCV NS3, NS5A, and NS5B in daa therapy failure patients Journal of Hepatology ·S. Süsser, Julius-Maximilians-Universität Würzburg, Sieglinde Kofler, Tania M. Welzel, D. Perner, Stefan Zeuzem, C. Sarrazin	2015	3
17	506 UNDETECTABLE HCV-RNA IN TELAPREVIR-TREATED PATIENTS: LOW CONCORDANCE BETWEEN TWO HIGHLY SENSITIVE REAL-TIME PCR ASSAYS Journal of Hepatology ·Johannes Vermehren, Alessio Aghemo, Kai‐Henrik Peiffer, S. Süsser, Roberta D’Ambrosio, D. Perner, Lynn H. Gerber, R. Soffredini, Ola Weiland, Stefan Zeuzem, Massimo Colombo, C. Sarrazin	2013	2
18	P0895 : Comparison of three sequencing methods commonly used in hepatitis C virus resistance analysis: population-based vs. clonal vs. ultra deep sequencing Journal of Hepatology ·S. Süsser, Bastian Beggel, D. Perner, C. Berkowski, Stefan Zeuzem, Thomas Lengauer, Christoph Sarrazin	2015	2
19	P0818 : Analysis of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy Journal of Hepatology ·Julia Dietz, Daniel Rupp, D. Perner, C. Berkowski, Madeline Rader, S. Süsser, Stefan Mauss, Thomas Kuntzen, Stefan Zeuzem, Ralf Bartenschlager, Christoph Sarrazin	2015	1
20	P0766 : Epidemiology of viral resistance in genotype 1 infected patients at approval of IFN-free DAA combination therapy of chronic hepatitis C in Germany Journal of Hepatology ·Harald Farnik, Johannes Vermehren, S. Süsser, Julia Dietz, D. Perner, C. Berkowski, Stefan Zeuzem, Christoph Sarrazin	2015	1

About D. Perner

D. Perner is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Virology and Rheumatology, having authored 22 papers that have together received 390 indexed citations. Recurring topics across this work include Hepatitis C virus research (20 papers), Hepatitis B Virus Studies (9 papers), HIV/AIDS drug development and treatment (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Systemic Lupus Erythematosus Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HIV Research and Treatment (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Hepatology (355 citations), Epidemiology (315 citations), Infectious Diseases (108 citations), Virology (12 citations) and Rheumatology (27 citations). D. Perner has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Christoph Sarrazin, S. Süsser, Stefan Zeuzem, Johannes Vermehren, Julia Dietz, Stefan Zeuzem, Martin Welker, Nicole Forestier, Gavin Cloherty and Kai‐Henrik Peiffer. Their work appears in journals such as Journal of Hepatology, PLoS ONE, Journal of Clinical Virology, Journal of Viral Hepatitis and Human Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact